Tender detail

Anaesthetics and muscle relaxants

Summary

Tartu University Hospital Foundation is procuring a framework agreement for anaesthetic and neuromuscular blocking medicines in 29 lots. The lots cover products with specified active ingredients, strengths and pack sizes, including remifentanil, propofol, local anaesthetics, midazolam, dexmedetomidine and muscle relaxants. Deliveries are intended for the hospital pharmacies in Tartu and Põlva.

Reference number
315950-0000
Buyer
sihtasutus Tartu Ülikooli Kliinikum
Country
Estonia (EST)
Procedure
Open procedure
CPV
33600000 Pharmaceutical products
Deadline
2026-11-09
Status
Evaluation
Contract subject
Supplies
Estimated value
Not published
Source
RHR

Participation requirements

Tender requirements are available in the official tender documents.

Compliance requirements

Exclusion grounds include final convictions within the last five years, or an exclusion period still in force, for participation in a criminal organisation, corruption, fraud, terrorism-related offences, money laundering or terrorist financing, and child labour or other forms of human trafficking. Grounds also include breaches of tax or social security payment obligations; bankruptcy, insolvency, liquidation, suspension of business or similar circumstances; serious professional misconduct; agreements intended to distort competition; unmanageable conflicts of interest; involvement in preparing the procurement where an unfair advantage cannot otherwise be prevented; and serious or repeated breaches of previous contracts resulting in early termination, damages, price reduction or penalties. A bidder may also be excluded for false or misleading information, withholding required information or documents, or improperly seeking confidential information. National grounds include enabling the unlawful employment of a foreign national, being subject to international sanctions in a way that would make the contract unlawful, and relevant tax-crime convictions. Where legally permitted, a bidder may provide evidence of measures taken to restore its reliability.

Qualification criteria and exclusion grounds

Bidders must submit the participation application in Annex 4, Form II, and a compliant technical offer in Excel format using Annex 1 for each lot bid. The offer must identify the medicine’s active ingredient, original product name, pharmaceutical form, dose, manufacturer, unit price and total price. The offered medicine must have a valid marketing authorisation in Estonia, and the bidder must hold an Estonian wholesale medicines licence; the bidder confirms both in the application, and the contracting authority checks them in the relevant official registers. Where a medicine lacks an Estonian marketing authorisation or the relevant professional association application, the contracting authority will apply to the Medicines Agency for import authorisation. Any proposed equivalent must be explained and supported by evidence. Prices must be stated in euros, excluding VAT, and include all delivery and unloading costs to the Tartu University Hospital pharmacy at L. Puusepa 8, Tartu, and Põlva Hospital pharmacy at Uus 2, Põlva; quoted unit prices are final. Joint bidders must appoint an authorised representative and submit the power of attorney and confirmation of joint and several liability using Annex 4, Form I. The bidder must also confirm that the goods are not subject to international sanctions and are not from sanctioned territories, and that subcontractors or suppliers representing more than 10% of the contract value are not Russian persons or entities, entities more than 50% owned by them, or persons acting on their behalf or instructions. The offer must follow the prescribed price structure. The provided text does not specify the award-scoring method; check the official tender documents for the evaluation details.